Fuska J, Proksa B, Fusková A
Neoplasma. 1975;22(3):335-8.
Bikaverin and its derivatives have been found to affect precursor utilization of nucleic acid and protein synthesis in the cells of Ehrlich ascites carcinoma (EAC). Mainly the uridine incorporation into EAC cells was inhibited. This is in agreement with the known concept that anthraquinones, to which bikaverin may also be assigned, intervene into RNA synthesis. The substances followed exerted a cytotoxic effect on in vitro proliferating cells of the three studied tumors. The ED50 values found for cells of these tumors were: EAC 0.5 mug/ml; leukemia L 5178 1.4 mug/ml; sarcoma 37 4.2 mug/ml.
已发现比卡维林及其衍生物会影响艾氏腹水癌(EAC)细胞中核酸和蛋白质合成的前体利用。主要是尿苷掺入EAC细胞受到抑制。这与已知的概念一致,即比卡维林也可能归属的蒽醌类物质会干预RNA合成。随后这些物质对所研究的三种肿瘤的体外增殖细胞产生了细胞毒性作用。这些肿瘤细胞的半数有效剂量(ED50)值分别为:EAC 0.5微克/毫升;白血病L 5178 1.4微克/毫升;肉瘤37 4.2微克/毫升。